| |
| | Prostar Percutaneous Vascular Surgery Systems Available in the U.S. (Site not responding. Last check: ) |
 | | Prostar Percutaneous Vascular Surgery Systems Available in the U.S. MENLO PARK, Calif., April 30, 1997 -- The Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Prostar(R) 9F and 11F Percutaneous Vascular Surgery Systems for clinical use in the United States. |
 | | The Prostar system, developed by Perclose, Inc., has been used in Europe and Japan for approximately two years. |
 | | The system offers the option of minimally invasive surgical closure, including better clinical treatment options for the coronary arteries, earlier ambulation and improved comfort following coronary catheterization procedures, according to Simpson. |
| www.pslgroup.com /dg/2501E.htm (481 words) |
|